Viewing Study NCT06501651

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-02-21 @ 10:44 PM
Study NCT ID: NCT06501651
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-15
First Post: 2024-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy
Sponsor: Sichuan Academy of Medical Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Essential Hypertension View
None Type 2 Diabetes View
None Nephropathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Essential hypertension View
None Type 2 diabetes View
None Nephropathy View
None Sacubitril/Valsartan View